Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: a network meta-analysis and regression

CONCLUSIONS: Drug rankings may guide antipsychotic switching toward metabolically safer drugs. Mechanistic insights may suggest improvements for combination therapies and drug development. More data are required regarding newer antipsychotics.PMID:33622426 | DOI:10.1017/S0033291721000180

Source: Psychological Medicine - February 24, 2021 Category: Psychiatry Authors: Carla Carnovale Ersilia Lucenteforte Vera Battini Faizan Mazhar Marco Fornili Elena Invernizzi Giulia Mosini Michele Gringeri Annalisa Capuano Cristina Scavone Maria Nobile Chiara Vantaggiato Simone Pisano Carmela Bravaccio Sonia Radice Emilio Clementi Ma Source Type: research